View Author
scopus: 7201370908

Arnold, A.E.R.

(Alfred Arnold)


patient group thrombolytic therapy treatment trial infarction therapy case simulations thrombolytic study alteplase mortality stenosi cardiologist infusion angiography hospital aortic analysis infarct size 1 patient simulation heart decision angioplasty reocclusion vessel infarct reinfarction difference thrombolysi alteplase /ptca trial advice aortic valve replacement streptokinase function valve infarct-related tissue-type plasminogen activator aortic stenosis table alteplase /placebo trial heparin artery result surgery baseline risk placebo strategy rt-pa activator benefit number characteristic ejection fraction hospital discharge discharge plasminogen intracranial 1 year tissue plasminogen activator confidence model baseline percutaneous transluminal disease interval aortic valve area effect study group intracoronary streptokinase angiogram aspirin grade death patent class replacement survival vignette




10 Most Recent Publications

Validity of conjoint analysis to study cardiologists' decisions for elderly patients with aortic stenosis (Article)
Bouma, B.J. Meulen, J.H.P. van der Brink, R.B.A. van den Smidts, A. Cherieux, E.C. Hamer, J.H.P. Lei, K.I. Tijssen, J.G.P. Arnold, A.E.R.
2004-08-01
Variability in treatment advice for elderly patients with aortic stenosis: a nationwide survey in the Netherlands (Article)
Bouma, B.J. Meulen, J.H.P. van der Brink, R.B.A. van den Smidts, A. Teunter, L.H. Lie, K.I. Arnold, A.E.R.
2001-01-01
Estimated gain in life expectancy (Article)
Vlugt, M.J. van der Arnold, A.E.R. Deckers, J.W. Simoons, M.L. Boersma, H.
1996-01-01
Benefit of Thrombolytic Therapy is Sustained Throughout Five Years and Is Related to TIMI Perfusion Grade 3 But Not Grade 2 Flow at Discharge (Article)
Lenderink, T. Simoons, M.L. Es, G.A. van Verstraete, M. Arnold, A.E.R. Werf, F.J.J. van de
1995-01-01
Thrombolytic therapy for evolving myocardial infarction needs an approach that integrates benefit and risk (Article)
Arnold, A.E.R. Simoons, M.L.
1995-01-01
Tailored thrombolytic therapy. A perspective (Article)
Simoons, M.L. Arnold, A.E.R.
1993-01-01
Recombinant tissue-type plasminogen activator and immediate angioplasty in acute myocardial infarction. (Article)
Arnold, A.E.R. Simoons, M.L. Bono, D.P. de Tijssen, J.G.P. Serruys, P.W.J.C. Verstraete, M. Lubsen, J. Werf, F.J.J. van de
1992-01-01
Reasons for the lack of benefit of immediate angioplasty during recombinant tissue plasminogen activator therapy for acute myocardial infarction: a regional wall motion analysis (Article)
Serruys, P.W.J.C. Rutsch, W.R. Simoons, M.L. Bono, D.P. de Tijssen, J.G.P. Lubsen, J. Verstraete, M. Arnold, A.E.R.
1991-01-01
Increased serum levels of fibrinogen degradation products due to treatment with recombinant tissue-type plasminogen activator for acute myocardial infarction are related to bleeding complications, but not to coronary patency (Article)
Brower, R.W. Collen, D. Es, G.A. van Lubsen, J. Serruys, P.W.J.C. Simoons, M.L. Verstraete, M. Arnold, A.E.R.
1989-01-01
Trombolytische therapie van het acute hartinfarct (Article)
Arnold, A.E.R. Simoons, M.L. Lubsen, J.
1989-01-01